Agilent and Picometrics Ink Deal to Provide Tools for Biopharmaceutical Characterization | GenomeWeb

NEW YORK (GenomeWeb News) – Agilent said today that it has signed a co-marketing agreement with Picometrics Technologies to provide combined solutions for capillary electrophoresis, laser induced fluorescence detection, and mass spectrometry for biopharmaceutical applications.

The platform is intended for the research and development of complex large-molecule biopharmaceutical compounds, and is the only online CE-LIF-MS solution currently available, Agilent said.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Pacific Biosciences is hosting a competition in which researchers are vying to win free sequencing for an organism with the most interesting genome.

An opinion piece appearing in Newsday likens familial DNA searches to stop-and-frisk policies.

The San people of Africa have drawn up a code of conduct for researchers, according to the Conversation.

In Nature this week: genotypes linked to hip osteoarthritis, and more.